World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 



Vanga Varshitha*, Ummarha Mahmeen, Rauth Sachin, Borgia Venkatesh and Dr. R. Sandhya Rani


Background: The metabolic syndrome is characterized by clustering of risk factors, which predisposes subjects to increased risk of diabetes and cardiovascular disease. Objectives of our study were to estimate prevalence of the metabolic syndrome and determine the relation and association of risk factors with the metabolic syndrome, to understand the influence of unhealthy life style pattern with existing co-morbidities. Methodology: Prospective study, community-based study conducted from April 2021-june 2021. A total of 234 subjects were included in the study. A total of 132 samples are exhibiting positive results from calculating risk meters including BMI, WC, Family history, Past/Present illness, Diet, Physical activity, behavioural factors and socioeconomic status excluding biochemical tests. Results: The total numbers of male subjects included in the study were 73 whereas female subjects are 56. The prevalence of the metabolic syndrome was 31.4% and 24.6% using WHO and AHA/NHLBI criteria respectively. Risk factors were age above 35 years, family history of diabetes, CVS and body mass index (BMI) above 23.9 kg/m2. Both Healthy diet and physical activity was not practiced by 21.3% which plays a major role to prevent Metabolic syndrome. Conclusion: The prevalence of the metabolic syndrome was high in selected population in Hyderabad, Telangana India. Higher BMI and low intake of fruits and vegetables are modifiable by life style modification. Following sedentary life style which in future plays a role to develop metabolic syndrome. Subjects are considered at risk to have Metabolic syndrome when they have comorbid conditions, family history, unhealthy life style practice, then the prevalence of Metabolic syndrome in selected population is 56.4%.

[Full Text Article]   [Download Certificate]


  All Since 2019
 Citation  422  322
 h-index  9  7
 i10-index  4  2



    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here